{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:54:44Z","timestamp":1791924884062,"version":"4.3.4"},"reference-count":56,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":112,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA220508"],"award-info":[{"award-number":["CA220508"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA257881"],"award-info":[{"award-number":["P50CA257881"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>We performed whole-exome sequencing of 250 unique tumor tissues from 30 multi-region sampled pancreatic cancer research autopsies from patients diagnosed with advanced-stage disease. Convergent evolution within the TGF\u03b2 pathway is a common feature of advanced-stage disease. However, SMAD4 inactivation is more common among de novo metastatic pancreatic ductal adenocarcinomas (PDAC), whereas inactivation of TGF\u03b2 surface receptors is more common among locally advanced nonmetastatic cancers. These differences in metastatic propensity were orthogonally validated in mice by orthotopic injections of PDAC organoids with SMAD4 versus TGFBR2 inactivation. No functionally deleterious driver gene mutations were identified that were attributed to treatment, although irradiated PDACs had significantly greater genomic complexity and distinct mutational signatures compared with PDACs managed by chemotherapy. These findings provide a high-level profile of the genetic features distinguishing locally advanced from metastatic PDAC, potentially serving as a biomarker of borderline resectable or locally advanced PDACs most likely to benefit from neoadjuvant chemoradiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study fills an important gap in knowledge related to the characteristics of genomic alterations of advanced-stage disease. We expect that these findings will serve as a baseline reference set to identify mechanisms of resistance as novel therapies continue to become available for patients with PDAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-24-0772","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:20:16Z","timestamp":1770416416000},"page":"1087-1099","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Convergence for Inactivation of TGF\u03b2 Signaling Is a Common Feature of Advanced Pancreatic Cancer"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5998-2102","authenticated-orcid":false,"given":"Jungeui","family":"Hong","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 2 Department of Pathology and Laboratory Medicine, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 3 Human Oncology and Pathogenesis Program, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3220-6673","authenticated-orcid":false,"given":"Zachary A.","family":"Kohutek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Vanderbilt University Medical Center 4 Department of Radiation Oncology, , Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-9491","authenticated-orcid":false,"given":"Haochen","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 5 Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-1407","authenticated-orcid":false,"given":"Nicolas","family":"Lecomte","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 2 Department of Pathology and Laboratory Medicine, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 3 Human Oncology and Pathogenesis Program, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-1519","authenticated-orcid":false,"given":"Elias-Ramzey","family":"Karnoub","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 2 Department of Pathology and Laboratory Medicine, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0292-7882","authenticated-orcid":false,"given":"Rajya","family":"Kappagantula","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 2 Department of Pathology and Laboratory Medicine, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 3 Human Oncology and Pathogenesis Program, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3096-652X","authenticated-orcid":false,"given":"Laura D.","family":"Wood","sequence":"additional","affiliation":[{"name":"6Division of Gastrointestinal Pathology, Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8076-9199","authenticated-orcid":false,"given":"Eileen M.","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 7 Department of Medicine, , New York, New York."},{"name":"8Department of Medicine, Weill Cornell Medicine, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-146X","authenticated-orcid":false,"given":"Marsha","family":"Reyngold","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 9 Department of Radiation Oncology, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-2784","authenticated-orcid":false,"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 9 Department of Radiation Oncology, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-3023","authenticated-orcid":false,"given":"Christine A.","family":"Iacobuzio-Donahue","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 1 David M. Rubenstein Center for Pancreatic Cancer Research, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 2 Department of Pathology and Laboratory Medicine, , New York, New York."},{"id":[{"id":"https:\/\/ror.org\/02yrq0923","id-type":"ROR","asserted-by":"publisher"}],"name":"Memorial Sloan Kettering Cancer Center 3 Human Oncology and Pathogenesis Program, , New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2026060103135763400_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"2026060103135763400_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41575-021-00463-z","article-title":"The pancreatic cancer genome revisited","volume":"18","author":"Hayashi","year":"2021","journal-title":"Nat Rev Gastroentero"},{"key":"2026060103135763400_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","article-title":"Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution","volume":"52","author":"Chan-Seng-Yue","year":"2020","journal-title":"Nat Genet"},{"key":"2026060103135763400_bib4","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1016\/j.cell.2021.09.022","article-title":"Spatially confined sub-tumor microenvironments in pancreatic cancer","volume":"184","author":"Gr\u00fcnwald","year":"2021","journal-title":"Cell"},{"key":"2026060103135763400_bib5","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","article-title":"Early detection of pancreatic cancer: opportunities and challenges","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"key":"2026060103135763400_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"2026060103135763400_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13014-019-1309-x","article-title":"Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results","volume":"14","author":"Reyngold","year":"2019","journal-title":"Radiat Oncol"},{"key":"2026060103135763400_bib8","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J Clin Oncol"},{"key":"2026060103135763400_bib9","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.3390\/cancers12113402","article-title":"Oligometastatic pancreatic cancer to the liver in the era of neoadjuvant chemotherapy: which role for conversion surgery? A systematic review and meta-analysis","volume":"12","author":"De Simoni","year":"2020","journal-title":"Cancers"},{"key":"2026060103135763400_bib10","first-page":"1","volume-title":"Pancreatic cancer biology and genetics from an evolutionary perspective","author":"Makohon-Moore","year":"2016"},{"key":"2026060103135763400_bib11","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1158\/0008-5472.CAN-15-1337","article-title":"Application of evolutionary principles to cancer therapy","volume":"75","author":"Enriquez-Navas","year":"2015","journal-title":"Cancer Res"},{"key":"2026060103135763400_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","article-title":"Resolving genetic heterogeneity in cancer","volume":"20","author":"Turajlic","year":"2019","journal-title":"Nat Rev Genet"},{"key":"2026060103135763400_bib13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/2159-8290.CD-19-1508","article-title":"The evolutionary origins of recurrent pancreatic cancer","volume":"10","author":"Sakamoto","year":"2020","journal-title":"Cancer Discov"},{"key":"2026060103135763400_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2026060103135763400_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41559-022-01790-3","article-title":"Population genetics of clonally transmissible cancers","volume":"6","author":"N\u00ed Leathlobhair","year":"2022","journal-title":"Nat Ecol Evol"},{"key":"2026060103135763400_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng.3214","article-title":"A Big Bang model of human colorectal tumor growth","volume":"47","author":"Sottoriva","year":"2015","journal-title":"Nat Genet"},{"key":"2026060103135763400_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s43018-019-0002-1","article-title":"Intratumor heterogeneity reflects clinical disease course","volume":"1","author":"Iacobuzio-Donahue","year":"2020","journal-title":"Nat Cancer"},{"key":"2026060103135763400_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"2026060103135763400_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","author":"Raphael","year":"2017","journal-title":"Cancer Cell"},{"key":"2026060103135763400_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ng.3764","article-title":"Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer","volume":"49","author":"Makohon-Moore","year":"2017","journal-title":"Nat Genet"},{"key":"2026060103135763400_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-025-02468-9","article-title":"Genomic evolution of pancreatic cancer at single-cell resolution","volume":"58","author":"Zhang","year":"2026","journal-title":"Nat Genet"},{"key":"2026060103135763400_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ejhg.2010.198","article-title":"Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling","volume":"19","author":"McWilliams","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"2026060103135763400_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"DPC4, A candidate tumor suppressor gene at human chromosome 18q21.1","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"key":"2026060103135763400_bib24","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3390\/cancers13205086","article-title":"TGF\u03b2 signaling in the pancreatic tumor microenvironment","volume":"13","author":"Principe","year":"2021","journal-title":"Cancers"},{"key":"2026060103135763400_bib25","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.3390\/ijms21103534","article-title":"SMAD4 and the TGF\u03b2 pathway in patients with pancreatic ductal adenocarcinoma","volume":"21","author":"Dardare","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026060103135763400_bib26","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","article-title":"Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-\u03b2 signaling in cooperation with active Kras expression","volume":"20","author":"Ijichi","year":"2006","journal-title":"Genes Dev"},{"key":"2026060103135763400_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1078-0432.CCR-15-1615","article-title":"Mutant p53 together with TGF\u03b2 signaling influence organ-specific hematogenous colonization patterns of pancreatic cancer","volume":"23","author":"Zhong","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2026060103135763400_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41467-023-36344-z","article-title":"Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"key":"2026060103135763400_bib29","doi-asserted-by":"crossref","first-page":"e108389","DOI":"10.15252\/embj.2021108389","article-title":"Cancer evolution: Darwin and beyond","volume":"40","author":"Vendramin","year":"2021","journal-title":"EMBO J"},{"key":"2026060103135763400_bib30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.aat7171","article-title":"Minimal functional driver gene heterogeneity among untreated metastases","volume":"361","author":"Reiter","year":"2018","journal-title":"Science"},{"key":"2026060103135763400_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","article-title":"Patterns of somatic structural variation in human cancer genomes","volume":"578","author":"Li","year":"2020","journal-title":"Nature"},{"key":"2026060103135763400_bib32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cell.2013.04.010","article-title":"Diverse mechanisms of somatic structural variations in human cancer genomes","volume":"153","author":"Yang","year":"2013","journal-title":"Cell"},{"key":"2026060103135763400_bib33","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"2026060103135763400_bib34","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1038\/ncomms12605","article-title":"Mutational signatures of ionizing radiation in second malignancies","volume":"7","author":"Behjati","year":"2016","journal-title":"Nat Commun"},{"key":"2026060103135763400_bib35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41580-020-00297-8","article-title":"The molecular basis and disease relevance of non-homologous DNA end joining","volume":"21","author":"Zhao","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026060103135763400_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tig.2021.08.007","article-title":"Therapeutic and prognostic insights from the analysis of cancer mutational signatures","volume":"38","author":"Brady","year":"2022","journal-title":"Trends Genet"},{"key":"2026060103135763400_bib37","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026060103135763400_bib38","first-page":"3380","volume-title":"Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer","author":"Shinde","year":"2018"},{"key":"2026060103135763400_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ccell.2018.11.009","article-title":"The roles of initiating truncal mutations in human cancers: the order of mutations and tumor cell type matters","volume":"35","author":"Levine","year":"2019","journal-title":"Cancer Cell"},{"key":"2026060103135763400_bib40","doi-asserted-by":"crossref","first-page":"14114","DOI":"10.1038\/ncomms14114","article-title":"Reconstructing metastatic seeding patterns of human cancers","volume":"8","author":"Reiter","year":"2017","journal-title":"Nat Commun"},{"key":"2026060103135763400_bib41","first-page":"D731","article-title":"The year of the rat: the rat genome database at 20: a multi-species knowledgebase and analysis platform","volume":"48","author":"Smith","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2026060103135763400_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41588-020-0628-z","article-title":"Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases","volume":"52","author":"Hu","year":"2020","journal-title":"Nat Genet"},{"key":"2026060103135763400_bib43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"2026060103135763400_bib44","doi-asserted-by":"crossref","first-page":"283ra54","DOI":"10.1126\/scitranslmed.aaa1408","article-title":"Clonal status of actionable driver events and the timing of mutational processes in cancer evolution","volume":"7","author":"McGranahan","year":"2015","journal-title":"Sci Transl Med"},{"key":"2026060103135763400_bib45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/cncr.30430","article-title":"The challenges of tumor genetic diversity","volume":"123","author":"Mroz","year":"2017","journal-title":"Cancer"},{"key":"2026060103135763400_bib46","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/sj.onc.1204322","article-title":"Chromatin remodeling: why it is important in cancer","volume":"20","author":"Wolffe","year":"2001","journal-title":"Oncogene"},{"key":"2026060103135763400_bib47","doi-asserted-by":"crossref","first-page":"e1500447","DOI":"10.1126\/sciadv.1500447","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics","volume":"1","author":"Kadoch","year":"2015","journal-title":"Sci Adv"},{"key":"2026060103135763400_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1874467212666190215112915","article-title":"Targeting chromatin remodeling for cancer therapy","volume":"12","author":"Kaur","year":"2019","journal-title":"Curr Mol Pharmacol"},{"key":"2026060103135763400_bib49","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","article-title":"Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes","volume":"184","author":"Dentro","year":"2021","journal-title":"Cell"},{"key":"2026060103135763400_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"2026060103135763400_bib51","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2026060103135763400_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"2026060103135763400_bib53","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026060103135763400_bib54","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41568-019-0185-x","article-title":"An analysis of genetic heterogeneity in untreated cancers","volume":"19","author":"Reiter","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2026060103135763400_bib55","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2026060103135763400_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-24-0772\/3736239\/cd-24-0772.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-24-0772\/3790501\/cd-24-0772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/6\/1087\/3799140\/cd-24-0772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/6\/1087\/3799140\/cd-24-0772.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:14:15Z","timestamp":1780298055000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/6\/1087\/785541\/Convergence-for-Inactivation-of-TGF-Signaling-Is-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,2,9]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-24-0772","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.8509398","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.32530470","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530458","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530425","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530437","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530416","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530449","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530428","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530419","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530461","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530440","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530452","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530431","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530464","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530443","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530422","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530455","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530434","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530467","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530413","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32530446","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]}}}